Idenix Pharmaceuticals, Inc. (NASDAQ:IDIX)

CAPS Rating: 2 out of 5

A biopharmaceutical company engaged in the discovery, development and commercialization of drugs for the treatment of human viral and other infectious diseases with operations in the United States and Europe.

Recs

0
Player Avatar portefeuille (99.75) Submitted: 12/8/2011 1:55:09 PM : Outperform Start Price: $3.05 IDIX Score: +217.09

There are currently 4000 IDIX shares in my "fund" with break-even of around 5.92 USD.
http://caps.fool.com/Blogs/fund-trades/671856.

Report this Post 1 Comment
Member Avatar portefeuille (99.75) Submitted: 3/14/2012 1:14:27 PM
Recs: 0

now 2000 shares in the fund with break-even of around 0.10 USD.
http://caps.fool.com/Blogs/fund-trades/716433.

Featured Broker Partners


Advertisement